Invest in your brain health

Play a part in developing predictive algorithms for epilepsy, Alzheimer’s, and Parkinson’s disease.
This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For risks relating to this offering, see the Subscription Agreement for this offering.
The Importance of Sanitary, Disposable NeuroCap
A recent report indicated that more than one-third of coronavirus patients had some type of neurologic symptom. Neurologists and other medical practitioners are urged to follow sanitary techniques to avoid spreading COVID-19 through cross-contamination.

We believe that disposable EEG headset NeuroCap can help flatten the Covid-19 curve.
Why Invest?
Brain Scientific’s mission is to develop algorithms to detect neurological disorders, including epilepsy, memory dementia, and pre-Alzheimer’s diagnosis.
Neurological disorders are increasingly recognized as major causes of death and disability worldwide. More than 50 million people have epilepsy worldwide.
It is estimated that this number will almost double
World Health Organization, 2020

    First Name

    Last Name

    Email Address


    Yes, I would like to receive future communications from Brain Scientific Inc.

    Our first commercialized products, NeuroCap and NeuroEEG, aim to disrupt the expensive EEG market with economic and disposable substitutes that permit any medical professional in any setting to diagnose patients remotely within minutes.
    We want to improve patient access to neurological care and provide analysis through artificial intelligence (AI) to improve diagnosis. To achieve this, we plan 
to create a database of normal and abnormal brains for detecting seizures and dementia, and AI and machine learning processes will help detect
    abnormal activity.
    Market Demand
    The brain monitoring industry is composed of smaller markets that aim to understand, diagnose, treat, and cure mental conditions. These emerging industries account for a majority of the growth in the brain monitoring industry, and drive the need for improved brain monitoring technology.
    Neurological Condition and Number
    of Diagnosed Individuals
    Alzheimer’s disease
    40 million
    Sports-related head injuries
    446,788 (US Only)
    350 million
    50 million
    6.4 million
    795,000 (per year)
    Sleep disorders
    150 million
    47.5 million
    37 million
    Here is
    the math
    Someone in the world develops
    dementia every 3 seconds.
    It is estimated that globally there are 47.5
    million people with dementia, with 7.7
    million new cases every year. Alzheimer's
    disease is the most common cause of
    dementia and may contribute to 60–70%
    of cases.
    Around 50 million
    people worldwide  have epilepsy,
    making it one of the most
    common neurological
    diseases globally.
    Nearly 80% of people with epilepsy live in
    low- and middle-income countries. It is
    estimated that up to 70% of people living
    with epilepsy could live seizure-free if
    properly diagnosed and treated.
    About 1% of Americans
    have some form
    of epilepsy, and nearly
    4% (1 in 26) will develop
    epilepsy at some point in
    their lives.
    The number of Americans who have
    epilepsy is greater than the number
    who have multiple sclerosis, Parkinson's
    disease, and cerebral palsy combined.
    • Brain Scientific has developed two EEG devices to streamline EEG application and diagnosis:
      NeuroCap, a disposable EEG headset with 22 pre-gelled electrodes following the international 10–20 system, and NeuroEEG, a portable wireless EEG amplifier that is smaller than a deck of playing cards.
    • Brain Scientific has received FDA 510(k) clearance for NeuroCap and NeuroEEG in 2018
    • Successful early adopters program for NeuroCap and NeuroEEG (2018—2019)
    • Partner with industry leaders in EEG manufacturing and distributors to service national and global EEG market in progress
    • In 2018—2019, Brain Scientific has presented the company’s technology and devices at international and American conferences and trade shows
      including American Epilepsy Society (AES) Annual meetings, ASET, ACNS.
    Brain Scientific’s project on graphene EEG electrodes was chosen by Epilepsy Foundation for 2020 Shark Tank Competition Five Finalists
    Shark Tank Competition
    Our products are already operating across the
    country and have received good reviews
    Product Roadmap
    We are constantly working on new products to address new, growing markets.
    Developing product line extensions address new,
    growing markets: Pediatric and Long-Term Monitoring.
    1. Routine EEG
    New product for Routine market:
    NeuroCap-8 (with 8 channels)
    2. Pediatric EEG Caps
    New product for Routine market:
    NeuroCap-8 Pediatric
    3. Long -Term Monitoring
    New products for LTM market (24+ hours):
    NeuroCap-8 Adult, NeuroCap-19 Adult,
    NeuroCap-8 Pediatric, NeuroEEG
    Amplifier(24 channels)
    4. Artificial Intelligence
    New products for AI market: Brain
    E-Tattoo, Brain AI: Neutral Network
    enabled predictive capabilities for brain
    health / disease progression